Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL GIBSON

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1649217969
CMS profile
347020
Location
NASHVILLE, TN

General Payments · PY2018–2024

$152,018.13

  • Reported across 163 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$40,676.69

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $21,765.00 5
Travel and Lodging $13,816.93 6
Honoraria $3,600.00 2
Food and Beverage $1,340.91 21
Compensation for serving as faculty or as a speaker for a medical education program $153.85 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $38,880.53 36
PY2019 $30,433.94 51
PY2020 $8,369.40 4
PY2021 $12,863.75 8
PY2022 $15,937.16 19
PY2023 $4,856.66 10
PY2024 $40,676.69 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $16.34 01/18/2024 Food and Beverage Undisputed 01/23/2026 1139279256 CMS
Astellas Pharma US Inc $16.34 01/18/2024 Food and Beverage Undisputed 01/23/2026 1139279258 CMS
Astellas Pharma US Inc $16.34 01/18/2024 Food and Beverage Undisputed 01/23/2026 1139279260 CMS
Astellas Pharma US Inc $133.98 06/01/2024 Food and Beverage Undisputed 01/23/2026 1139348782 CMS
AstraZeneca Pharmaceuticals LP $153.85 10/31/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 1105662628 CMS
Bayer Healthcare Pharmaceuticals Inc. $111.26 01/19/2024 Food and Beverage Undisputed 01/23/2026 1086226140 CMS
BeiGene USA, Inc. $3,375.00 09/17/2024 Consulting Fee Undisputed 01/23/2026 1120867242 CMS
Coherus Biosciences Inc. $1,200.00 09/24/2024 Honoraria Undisputed 01/23/2026 1147276262 CMS
Daiichi Sankyo Inc. $9.76 05/16/2024 Food and Beverage Undisputed 01/23/2026 1089425853 CMS
Daiichi Sankyo Inc. $89.42 12/06/2024 Food and Beverage Undisputed 01/23/2026 1089425843 CMS
Daiichi Sankyo Inc. $312.22 12/06/2024 Travel and Lodging Undisputed 01/23/2026 1089425847 CMS
Daiichi Sankyo Inc. $312.22 12/07/2024 Travel and Lodging Undisputed 01/23/2026 1089425841 CMS
Daiichi Sankyo Inc. $107.94 12/07/2024 Travel and Lodging Undisputed 01/23/2026 1089425845 CMS
Daiichi Sankyo Inc. $12,538.20 12/07/2024 Travel and Lodging Undisputed 01/23/2026 1089425849 CMS
Daiichi Sankyo Inc. $8,750.00 12/19/2024 Consulting Fee Undisputed 01/23/2026 1089425835 CMS
E.R. Squibb & Sons, L.L.C. $23.99 02/12/2024 Food and Beverage Undisputed 01/23/2026 1101418529 CMS
E.R. Squibb & Sons, L.L.C. $85.21 07/17/2024 Food and Beverage Undisputed 01/23/2026 1101418561 CMS
E.R. Squibb & Sons, L.L.C. $115.97 11/13/2024 Food and Beverage Undisputed 01/23/2026 1101418583 CMS
Fosun Pharma USA Inc. $187.29 06/02/2024 Food and Beverage Undisputed 01/23/2026 1146938722 CMS
Fosun Pharma USA Inc. $2,400.00 06/25/2024 Honoraria Undisputed 01/23/2026 1146938720 CMS
JAZZ PHARMACEUTICALS INC. $3,500.00 08/04/2024 Consulting Fee Undisputed 01/23/2026 1150224964 CMS
Merck Sharp & Dohme LLC $3.66 11/15/2024 Food and Beverage Undisputed 01/23/2026 1141613728 CMS
Regeneron Pharmaceuticals, Inc. $39.33 01/10/2024 Food and Beverage Undisputed 01/23/2026 1114399233 CMS
Regeneron Pharmaceuticals, Inc. $97.64 01/10/2024 Food and Beverage Undisputed 01/23/2026 1114399235 CMS
Regeneron Pharmaceuticals, Inc. $133.83 01/10/2024 Food and Beverage Undisputed 01/23/2026 1114399237 CMS
Regeneron Pharmaceuticals, Inc. $112.70 01/10/2024 Food and Beverage Undisputed 01/23/2026 1114399239 CMS
Regeneron Pharmaceuticals, Inc. $53.53 01/10/2024 Food and Beverage Undisputed 01/23/2026 1114399241 CMS
Regeneron Pharmaceuticals, Inc. $49.31 01/10/2024 Food and Beverage Undisputed 01/23/2026 1114399243 CMS
Regeneron Pharmaceuticals, Inc. $461.35 01/10/2024 Travel and Lodging Undisputed 01/23/2026 1114399245 CMS
Regeneron Pharmaceuticals, Inc. $19.12 01/26/2024 Food and Beverage Undisputed 01/23/2026 1114399247 CMS
Regeneron Pharmaceuticals, Inc. $3.58 01/26/2024 Food and Beverage Undisputed 01/23/2026 1114399249 CMS
Regeneron Pharmaceuticals, Inc. $3,684.00 01/26/2024 Consulting Fee Undisputed 01/23/2026 1114399251 CMS
Regeneron Pharmaceuticals, Inc. $2,456.00 01/26/2024 Consulting Fee Undisputed 01/23/2026 1114399253 CMS
Regeneron Pharmaceuticals, Inc. $85.00 01/26/2024 Travel and Lodging Undisputed 01/23/2026 1114399255 CMS
Regeneron Pharmaceuticals, Inc. $22.31 06/27/2024 Food and Beverage Undisputed 01/23/2026 1114399257 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.